273 related articles for article (PubMed ID: 33668097)
1. Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer.
Nallanthighal S; Heiserman JP; Cheon DJ
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668097
[TBL] [Abstract][Full Text] [Related]
2. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
Liu Z; Lai J; Jiang H; Ma C; Huang H
FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
[TBL] [Abstract][Full Text] [Related]
3. Collagen XI Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment.
Wu YH; Chou CY
Front Oncol; 2022; 12():925165. PubMed ID: 35847935
[TBL] [Abstract][Full Text] [Related]
4. Collagen XI regulates the acquisition of collagen fibril structure, organization and functional properties in tendon.
Sun M; Luo EY; Adams SM; Adams T; Ye Y; Shetye SS; Soslowsky LJ; Birk DE
Matrix Biol; 2020 Dec; 94():77-94. PubMed ID: 32950601
[TBL] [Abstract][Full Text] [Related]
5. Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination.
Truong DQ; Ho BT; Chau GC; Truong DK; Pham TTT; Nakagawara A; Bui CB
Pediatr Dev Pathol; 2022; 25(2):91-98. PubMed ID: 34460335
[TBL] [Abstract][Full Text] [Related]
6. Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.
Wu YH; Huang YF; Chang TH; Chou CY
Int J Cancer; 2017 Dec; 141(11):2305-2317. PubMed ID: 28815582
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer.
Nallanthighal S; Rada M; Heiserman JP; Cha J; Sage J; Zhou B; Yang W; Hu Y; Korgaonkar C; Hanos CT; Ashkavand Z; Norman K; Orsulic S; Cheon DJ
Cell Death Dis; 2020 Apr; 11(4):258. PubMed ID: 32312965
[TBL] [Abstract][Full Text] [Related]
8. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C
Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316
[TBL] [Abstract][Full Text] [Related]
9. Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells.
Heiserman JP; Nallanthighal S; Gifford CC; Graham K; Samarakoon R; Gao C; Sage JJ; Zhang W; Higgins PJ; Cheon DJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638339
[TBL] [Abstract][Full Text] [Related]
10. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
[TBL] [Abstract][Full Text] [Related]
12. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function.
Wang H; Ren R; Yang Z; Cai J; Du S; Shen X
J Cancer; 2021; 12(5):1406-1420. PubMed ID: 33531986
[TBL] [Abstract][Full Text] [Related]
13. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression.
Vázquez-Villa F; García-Ocaña M; Galván JA; García-Martínez J; García-Pravia C; Menéndez-Rodríguez P; González-del Rey C; Barneo-Serra L; de Los Toyos JR
Tumour Biol; 2015 Apr; 36(4):2213-22. PubMed ID: 25761876
[TBL] [Abstract][Full Text] [Related]
14. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
[TBL] [Abstract][Full Text] [Related]
15. miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.
Wu YH; Huang YF; Chang TH; Wu PY; Hsieh TY; Hsiao SY; Huang SC; Chou CY
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944877
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic variation in
Yu H; Khanshour AM; Ushiki A; Otomo N; Koike Y; Einarsdottir E; Fan Y; Antunes L; Kidane YH; Cornelia R; Sheng RR; Zhang Y; Pei J; Grishin NV; Evers BM; Cheung JPY; Herring JA; Terao C; Song YQ; Gurnett CA; Gerdhem P; Ikegawa S; Rios JJ; Ahituv N; Wise CA
Elife; 2024 Jan; 12():. PubMed ID: 38277211
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast migration in non-small cell lung cancers is modulated by increased integrin α11 expression.
Iwai M; Tulafu M; Togo S; Kawaji H; Kadoya K; Namba Y; Jin J; Watanabe J; Okabe T; Hidayat M; Sumiyoshi I; Itoh M; Koyama Y; Ito Y; Orimo A; Takamochi K; Oh S; Suzuki K; Hayashizaki Y; Yoshida K; Takahashi K
Mol Oncol; 2021 May; 15(5):1507-1527. PubMed ID: 33682233
[TBL] [Abstract][Full Text] [Related]
18. COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
Wu YH; Chang TH; Huang YF; Huang HD; Chou CY
Oncogene; 2014 Jun; 33(26):3432-40. PubMed ID: 23934190
[TBL] [Abstract][Full Text] [Related]
19. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.
Wu YH; Chang TH; Huang YF; Chen CC; Chou CY
Oncotarget; 2015 Sep; 6(27):23748-63. PubMed ID: 26087191
[TBL] [Abstract][Full Text] [Related]
20. MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
